Advocates press Vertex to do more to widen access to cystic fibrosis treatments; A growing number of U.S. states, cities, and counties are suing insulin makers and PBMs

Taking stock of the drug industry, from the lab to the medicine chest

November 28, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Bill Sikes/AP STAT+ | Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it's not enough Patient advocates want Vertex to drop patent claims and implement a global pricing model reflecting R&D and production costs. By Ed Silverman STAT+ | A growing number of U.S. states, cities, and counties are suing insulin makers and PBMs The lawsuits claim companies artificially drove up the cost of insulin, making the diabetes medicine unaffordable for countless residents. By Ed Silverman and John Wilkerson How to spot when drug companies spin clinical trial results STAT has released the update of its Guide to Interpreting Clinical Trial Results, to help consumers of company readouts navigate the process. By STAT Staff Susan Walsh/AP STAT+ | Biden invokes Defense Production Act to stem drug shortages Biden's plan to stem drug shortages involves using the Defense Production Act, a Cold War-era law, to bring drug making back to the U.S. By John Wilkerson STAT+ | Argenx antibody fails study in platelet-destroying autoimmune disorder, derailing expansion plans The failure of the late-stage study to achieve its goals marked a setback in the company's efforts to expand the drug's use. By Adam Feuerstein STAT+ | Springworks wins FDA approval for drug to treat desmoid tumors The new drug, called Ogsiveo, is made by Springworks Therapeutics. It's the company's first approved medicine. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser